Kjetil Retterstøl
Position: Professor
Phone: +47 230 75617 / 90098393
Email:
 

Author network for Kjetil Retterstøl by COREMINE medical


Publications 2017

Bogsrud MP, Græsdal A, Retterstøl K, Holven KB (2017)
A physically fit woman in her thirties with exertional dyspnoea
Tidsskr Nor Laegeforen, 137 (6), 456-458
PubMed 28332800

Gjevestad GO, Ottestad I, Biong AS, Iversen PO, Retterstøl K, Raastad T, Skålhegg BS, Ulven SM, Holven KB (2017)
Consumption of protein-enriched milk has minor effects on inflammation in older adults-A 12-week double-blind randomized controlled trial
Mech Ageing Dev, 162, 1-8
PubMed 28163108

Publications 2016

Christensen JJ, Osnes L, Halvorsen B, Retterstøl K, Bogsrud MP, Wium C, Svilaas A, Narverud I, Ulven SM, Aukrust P, Holven KB (2016)
Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
Data Brief, 10, 587-592
PubMed 28070551

Christensen JJ, Osnes LT, Halvorsen B, Retterstøl K, Bogsrud MP, Wium C, Svilaas A, Narverud I, Ulven SM, Aukrust P, Holven KB (2016)
Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia
Atherosclerosis, 256, 67-74
PubMed 28024183

Christensen JJ, Retterstøl K, Godang K, Roland MC, Qvigstad E, Bollerslev J, Ueland T, Henriksen T, Holven KB (2016)
LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors
J Clin Lipidol, 10 (6), 1369-1378.e7
PubMed 27919354

Halvorsen B, Santilli F, Scholz H, Sahraoui A, Gulseth HL, Wium C, Lattanzio S, Formoso G, Di Fulvio P, Otterdal K, Retterstøl K, Holven KB, Gregersen I, Stavik B, Bjerkeli V, Michelsen AE, Ueland T, Liani R, Davi G, Aukrust P (2016)
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
Diabetologia, 59 (10), 2134-44
PubMed 27421726

Holme I, Retterstøl K, Norum KR, Hjermann I (2016)
Lifelong benefits on myocardial infarction mortality: 40-year follow-up of the randomized Oslo diet and antismoking study
J Intern Med, 280 (2), 221-7
PubMed 26924204

Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K (2016)
Low-carbohydrate diets increase LDL-cholesterol, and thereby indicate increased risk of CVD
Br J Nutr, 115 (12), 2264-6
PubMed 27376624

Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K (2016)
Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials
Br J Nutr, 115 (3), 466-79
PubMed 26768850

Mundal L, Igland J, Ose L, Holven KB, Veierød MB, Leren TP, Retterstøl K (2016)
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013
Eur J Prev Cardiol, 24 (2), 137-144
PubMed 27794106

Mundal L, Retterstøl K (2016)
A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries
Curr Opin Lipidol, 27 (4), 388-97
PubMed 27070076

Mundal L, Veierød MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterstøl K (2016)
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
Eur J Prev Cardiol, 23 (18), 1962-1969
PubMed 27558979

Nordstrom M, Paus B, Retterstol K, Kolset SO (2016)
The prevalence of metabolic risk factors of atherosclerotic cardiovascular disease in Williams syndrome, Prader-Willi syndrome, and Down syndrome
J. Intellect. Dev. Dis., 41 (3), 187-196

Pingitore P, Lepore SM, Pirazzi C, Mancina RM, Motta BM, Valenti L, Berge KE, Retterstøl K, Leren TP, Wiklund O, Romeo S (2016)
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia
J Clin Lipidol, 10 (4), 816-23
PubMed 27578112

Retterstøl K (2016)
[No title available]
Tidsskr Nor Laegeforen, 136 (18), 1508
PubMed 27731589

Retterstøl K (2016)
[Myocardial infarction, saturated fat and cholesterol]
Tidsskr Nor Laegeforen, 136 (14-15), 1205
PubMed 27554559

Torvik K, Narverud I, Ottestad I, Svilaas A, Gran JM, Retterstøl K, Ellingvåg A, Strøm E, Ose L, Veierød MB, Holven KB (2016)
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia
Atherosclerosis, 252, 21-7
PubMed 27494447

Publications 2015

Koopal C, Retterstøl K, Sjouke B, Hovingh GK, Ros E, de Graaf J, Dullaart RP, Bertolini S, Visseren FL (2015)
Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study
Atherosclerosis, 240 (1), 90-7
PubMed 25768710

Krogh HW, Mundal L, Holven KB, Retterstøl K (2015)
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Eur Heart J, 37 (17), 1398-405
PubMed 26586781

Langslet G, Bogsrud MP, Halvorsen I, Fjeldstad H, Retterstøl K, Veierød MB, Ose L (2015)
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood
J Clin Lipidol, 9 (6), 778-85
PubMed 26687698

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K (2015)
[Increased mortality in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 135 (11), 1024-5
PubMed 26080775

Narverud I, van Lennep JR, Christensen JJ, Versmissen J, Gran JM, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Ulven SM, Ose L, Veierød MB, Sijbrands E, Retterstøl K, Holven KB (2015)
Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
Atherosclerosis, 243 (1), 155-60
PubMed 26386212

Tjelle TE, Holtung L, Bøhn SK, Aaby K, Thoresen M, Wiik SÅ, Paur I, Karlsen AS, Retterstøl K, Iversen PO, Blomhoff R (2015)
Polyphenol-rich juices reduce blood pressure measures in a randomised controlled trial in high normal and hypertensive volunteers
Br J Nutr, 114 (7), 1054-63
PubMed 26227795

Publications 2014

Berge KE, Retterstøl K, Romeo S, Pirazzi C, Leren TP (2014)
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene
Atherosclerosis, 234 (1), 30-3
PubMed 24589565

Holven KB, Narverud I, Lindvig HW, Halvorsen B, Langslet G, Nenseter MS, Ulven SM, Ose L, Aukrust P, Retterstøl K (2014)
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Atherosclerosis, 233 (2), 561-7
PubMed 24530965

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K (2014)
Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
J Am Heart Assoc, 3 (6), e001236
PubMed 25468658

Narverud I, Retterstøl K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, Ose L, Aukrust P, Veierød MB, Holven KB (2014)
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
Atherosclerosis, 235 (2), 299-309
PubMed 24908240

Publications 2013

Baumann M, Espeland MZ, Kværner AS, Bogsrud MP, Retterstøl K (2013)
[Lipid profile of healthy persons with low-carbohydrate diet]
Tidsskr Nor Laegeforen, 133 (11), 1193-6
PubMed 23759780

Baumann M, Espeland MZ, Kværner AS, Bogsrud MP, Retterstøl K (2013)
[M. Baumann and colleagues replies]
Tidsskr Nor Laegeforen, 133 (16), 1685-6
PubMed 24005696

Bogsrud MP, Langslet G, Ose L, Arnesen KE, Sm Stuen MC, Malt UF, Woldseth B, Retterstøl K (2013)
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy
Scand Cardiovasc J, 47 (2), 80-7
PubMed 23301875

Bogsrud MP, Reikvam Å, Retterstøl K (2013)
[Treatment with statins]
Tidsskr Nor Laegeforen, 133 (12-13), 1316-9
PubMed 23817262

Holven KB, Retterstøl K, Ueland T, Ulven SM, Nenseter MS, Sandvik M, Narverud I, Berge KE, Ose L, Aukrust P, Halvorsen B (2013)
Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype
PLoS One, 8 (11), e78241
PubMed 24244297

Molven I, Retterstøl K, Andersen LF, Veierød MB, Narverud I, Ose L, Svilaas A, Wandel M, Holven KB (2013)
Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
J Nutr Sci, 2, e32
PubMed 25191582

Ottestad I, Ose L, Wennersberg MH, Granlund L, Kirkhus B, Retterstøl K (2013)
Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial
Atherosclerosis, 228 (2), 421-5
PubMed 23623012

Stormo C, Bogsrud MP, Hermann M, Åsberg A, Piehler AP, Retterstøl K, Kringen MK (2013)
UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
Mol Diagn Ther, 17 (4), 233-7
PubMed 23580084

Publications 2012

Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstøl K, Bryniarski L, Császár A, Vanderbist F (2012)
Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials
Clin Drug Investig, 32 (4), 281-91
PubMed 22350498

Farnier M, Retterstøl K, Steinmetz A, Császár A (2012)
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Diab Vasc Dis Res, 9 (3), 205-15
PubMed 22228773

Græsdal A, Bogsrud MP, Holven KB, Nenseter MS, Narverud I, Langslet G, Brekke M, Retterstøl K, Arnesen KE, Ose L (2012)
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
J Clin Lipidol, 6 (4), 331-9
PubMed 22836070

Narverud I, Halvorsen B, Nenseter MS, Retterstøl K, Yndestad A, Dahl TB, Ulven SM, Olstad OK, Ose L, Holven KB, Aukrust P (2012)
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
J Intern Med, 273 (1), 69-78
PubMed 22891927

Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
PubMed 23199546

Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Aukrust P, Retterstøl K, Ose L, Halvorsen B, Holven KB (2012)
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
J Clin Lipidol, 7 (2), 109-16
PubMed 23415429

Ottestad I, Retterstøl K, Myhrstad MC, Andersen LF, Vogt G, Nilsson A, Borge GI, Nordvi B, Brønner KW, Ulven SM, Holven KB (2012)
Intake of oxidised fish oil does not affect circulating levels of oxidised LDL or inflammatory markers in healthy subjects
Nutr Metab Cardiovasc Dis, 23 (1), e3-4
PubMed 23146358

Retterstøl K (2012)
[Omega-3 fatty acids--both food and medicine]
Tidsskr Nor Laegeforen, 132 (20), 2258
PubMed 23736186

Telle-Hansen VH, Narverud I, Retterstøl K, Wesseltoft-Rao N, Mosdøl A, Granlund L, Christiansen KF, Lamglait A, Halvorsen B, Holven KB, Ulven SM (2012)
Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects
J Nutr Sci, 1, e17
PubMed 25191546

Publications 2011

Farnier M, Steinmetz A, Retterstøl K, Császár A (2011)
Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study
Clin Ther, 33 (1), 1-12
PubMed 21397769

Myhrstad MC, Narverud I, Telle-Hansen VH, Karhu T, Lund DB, Herzig KH, Makinen M, Halvorsen B, Retterstøl K, Kirkhus B, Granlund L, Holven KB, Ulven SM (2011)
Effect of the fat composition of a single high-fat meal on inflammatory markers in healthy young women
Br J Nutr, 106 (12), 1826-35
PubMed 21736782

Myhrstad MC, Retterstøl K, Telle-Hansen VH, Ottestad I, Halvorsen B, Holven KB, Ulven SM (2011)
Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors
Inflamm Res, 60 (4), 309-19
PubMed 21229287

Nenseter MS, Lindvig HW, Ueland T, Langslet G, Ose L, Holven KB, Retterstøl K (2011)
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
Atherosclerosis, 216 (2), 426-32
PubMed 21376325

Ottestad I, Vogt G, Retterstøl K, Myhrstad MC, Haugen JE, Nilsson A, Ravn-Haren G, Nordvi B, Brønner KW, Andersen LF, Holven KB, Ulven SM (2011)
Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial
Br J Nutr, 108 (2), 315-26
PubMed 22136711

Skottheim IB, Bogsrud MP, Hermann M, Retterstøl K, Åsberg A (2011)
Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy
Mol Diagn Ther, 15 (4), 221-7
PubMed 21815705

Toleikyte I, Retterstøl K, Leren TP, Iversen PO (2011)
Pregnancy outcomes in familial hypercholesterolemia: a registry-based study
Circulation, 124 (15), 1606-14
PubMed 21911783

Publications 2010

Bogsrud MP, Ose L, Langslet G, Ottestad I, Strøm EC, Hagve TA, Retterstøl K (2010)
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study
Scand Cardiovasc J, 44 (4), 197-200
PubMed 20636227

Langslet G, Ottestad I, Retterstøl K, Ose L (2010)
[Clinical trials--viewpoints from participants]
Tidsskr Nor Laegeforen, 130 (16), 1606-8
PubMed 20805857

Narverud I, Ueland T, Nenseter MS, Retterstøl K, Telle-Hansen VH, Halvorsen B, Ose L, Aukrust P, Holven KB (2010)
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10
Atherosclerosis, 214 (1), 163-8
PubMed 21040915

Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrières J, Amouyel P, Lien S, Romeo J, Valtueña J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI (2010)
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
PubMed 20939869

Publications 2009

Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO (2009)
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
PubMed 18972234

Retterstøl K (2009)
Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue
Expert Opin Investig Drugs, 18 (9), 1405-11
PubMed 19678802

Retterstøl K, Hennig CB, Iversen PO (2009)
Improved plasma lipids and body weight in overweight/obese patients with type III hyperlipoproteinemia after 4 weeks on a low glycemic diet
Clin Nutr, 28 (2), 213-5
PubMed 19232793

Tobin KA, Holven KB, Retterstøl K, Strøm E, Ose L, Aukrust P, Nenseter MS (2009)
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
PubMed 19682403

Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
PubMed 19710195

Publications 2008

Blom DJ, Marais AD, Retterstøl K, Stein EA, Ycas J, Gu Z, Miller E (2008)
Rosuvastatin reduces non-high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia)
J Clin Lipidol, 2 (6), 418-25
PubMed 21291775

Holven KB, Aukrust P, Retterstøl K, Otterdal K, Bjerkeli V, Ose L, Nenseter MS, Halvorsen B (2008)
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects
J Nutr, 138 (11), 2070-5
PubMed 18936200

Nenseter MS, Ueland T, Retterstøl K, Strøm E, Mørkrid L, Landaas S, Ose L, Aukrust P, Holven KB (2008)
Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
Stroke, 40 (1), 241-7
PubMed 19008470

Retterstøl K (2008)
[The zero vision for arteriosclerotic cardiovascular disease in younger people]
Tidsskr Nor Laegeforen, 128 (10), 1188-90
PubMed 18480870

Publications 2007

Bogsrud MP, Sogstad A, Retterstøl K (2007)
[Practical advice for registration of clinical trials]
Tidsskr Nor Laegeforen, 127 (12), 1654-6
PubMed 17571106

Stein EA, Ose L, Retterstøl K, Tonstad S, Schleman M, Harris S, Sager P (2007)
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
J Clin Lipidol, 1 (4), 280-6
PubMed 21291692

Tonstad S, Retterstøl K, Ose L, Ohman KP, Lindberg MB, Svensson M (2007)
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
Metabolism, 56 (9), 1285-92
PubMed 17697874

Publications 2006

Amundsen AL, Khoury J, Iversen PO, Bergei C, Ose L, Tonstad S, Retterstøl K (2006)
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
Atherosclerosis, 189 (2), 451-7
PubMed 16466729

Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
PubMed 16914186

Hermann M, Bogsrud MP, Molden E, Asberg A, Mohebi BU, Ose L, Retterstøl K (2006)
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy
Clin Pharmacol Ther, 79 (6), 532-9
PubMed 16765141

Holven KB, Aukrust P, Retterstol K, Hagve TA, Mørkrid L, Ose L, Nenseter MS (2006)
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects
Scand J Clin Lab Invest, 66 (1), 45-54
PubMed 16464786

Holven KB, Halvorsen B, Bjerkeli V, Damås JK, Retterstøl K, Mørkrid L, Ose L, Aukrust P, Nenseter MS (2006)
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects
Stroke, 37 (7), 1731-6
PubMed 16728689

Publications 2005

Retterstøl K (2005)
Too low blood cholesterol?
Scand J Clin Lab Invest, 65 (1), 1-2
PubMed 15859021

Westerberg R, Månsson JE, Golozoubova V, Shabalina IG, Backlund EC, Tvrdik P, Retterstøl K, Capecchi MR, Jacobsson A (2005)
ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue
J Biol Chem, 281 (8), 4958-68
PubMed 16326704

Publications 2004

Hexeberg S, Retterstøl K (2004)
[Hypertriglyceridemia--diagnostics, risk and treatment]
Tidsskr Nor Laegeforen, 124 (21), 2746-9
PubMed 15534665

Publications 2001

Retterstøl K, Haugen TB, Tran TN, Christophersen BO (2001)
Studies on the metabolism of essential fatty acids in isolated human testicular cells
Reproduction, 121 (6), 881-7
PubMed 11373174

Retterstøl K, Tran TN, Haugen TB, Christophersen BO (2001)
Metabolism of very long chain polyunsaturated fatty acids in isolated rat germ cells
Lipids, 36 (6), 601-6
PubMed 11485164

Tran TN, Retterstøl K, Christophersen BO (2001)
Differences in the conversion of the polyunsaturated fatty acids [1-(14)C]22:4(n-6) and [1-(14)C]22:5(n-3) to [(14)C]22:5(n-6) and [(14)C]22:6(n-3) in isolated rat hepatocytes
Biochim Biophys Acta, 1532 (1-2), 137-47
PubMed 11420183

Publications 2000

Retterstøl K, Haugen TB, Christophersen BO (2000)
The pathway from arachidonic to docosapentaenoic acid (20:4n-6 to 22:5n-6) and from eicosapentaenoic to docosahexaenoic acid (20:5n-3 to 22:6n-3) studied in testicular cells from immature rats
Biochim Biophys Acta, 1483 (1), 119-31
PubMed 10601701

Retterstøl K, Lund AM, Tverdal S, Cristophersen BO (2000)
Metabolism of some radiolabeled essential fatty acids in isolated rat hepatocytes is affected by dietary ethanol
Alcohol, 21 (1), 19-26
PubMed 10946154

Publications 1999

Retterstøl K, Lund AM, Tverdal S, Christophersen BO (1999)
The metabolism of essential fatty acids in rat liver is influenced more by dietary fat than dietary ethanol
Lipids, 34 Suppl, S133-4
PubMed 10419122

Publications 1998

Retterstøl K, Haugen TB, Woldseth B, Christophersen BO (1998)
A comparative study of the metabolism of n-9, n-6 and n-3 fatty acids in testicular cells from immature rat
Biochim Biophys Acta, 1392 (1), 59-72
PubMed 9593823

Woldseth B, Retterstøl K, Christophersen BO (1998)
Monounsaturated trans fatty acids, elaidic acid and trans-vaccenic acid, metabolism and incorporation in phospholipid molecular species in hepatocytes
Scand J Clin Lab Invest, 58 (8), 635-45
PubMed 10088200

Publications 1996

Retterstøl K, Stugaard M, Gørbitz C, Ose L (1996)
Results of intensive long-term treatment of familial hypercholesterolemia
Am J Cardiol, 78 (12), 1369-74
PubMed 8970408

Retterstøl K, Woldseth B, Christophersen BO (1996)
The metabolism of 22:5(-6) and of docosahexaenoic acid [22:6(-3)] compared in rat hepatocytes
Biochim Biophys Acta, 1303 (3), 180-6
PubMed 8908151

Publications 1995

Retterstøl K, Woldseth B, Christophersen BO (1995)
Studies on the metabolism of [1-14C]5.8.11-eicosatrienoic (Mead) acid in rat hepatocytes
Biochim Biophys Acta, 1259 (1), 82-8
PubMed 7492619

Publications 1988

Everts ME, Retterstøl K, Clausen T (1988)
Effects of adrenaline on excitation-induced stimulation of the sodium-potassium pump in rat skeletal muscle
Acta Physiol Scand, 134 (2), 189-98
PubMed 2852445